Loading patent…
AssigneeAurora Algae, Inc.
InventorsJames Astwood, Michelle L. Collins, Brian Connolly
Estimating the term…
Provided herein are exemplary compositions, products, and capsules utilizing POA, EPA, blends of POA and EPA, total algal oil compositions, and/or whole biomass compositions in methods of inhibiting inflammation including in cardiovascular disease, diabetes, obesity, stroke, metabolic syndromes, dementia, Alzheimer's disease, and/or cancer. The exemplary compositions, products, and capsules may be orally, topically, intravenously, and/or subcutaneously administered. The exemplary compositions herein may be used as feed, food, food supplements, beverages, beverage supplements, nutritional products, products for athletic performance, pharmaceutical products, and/or medical products for mammalian use, including humans.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
A method for inhibiting inflammation of tissue of a mammalian subject, the method comprising administering at an effective dose a composition of:
(canceled)
(canceled)
(canceled)
(canceled)
A method for reducing in a human chronic inflammation, weight associated with obesity, and satiety, the method comprising orally administering on a daily basis for a treatment period of at least 30 days at least one capsule having at least approximately 25 percent of capsule volume comprising a composition further comprising by dry weight approximately 90% palmitoleic acid, less than approximately 0.5% saturated fatty acids, less than approximately 2% arachidonic acid, substantially no docosahexaenoic acid, and less than approximately 10% eicosapentaenoic acid, wherein the composition is in a form of an ethyl ester (EE).
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.